Τhe effects of obesity and diet on prostate cancer risk
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 6
Abstract
Prostate cancer is nowadays the most common malignancy in males of the western world, but little is as yet known regarding the causes of initiation and progression of this disease. To explain the geographical variations in the incidence of clinical prostate cancer, the changes in its prevalence in migrants moving from countries with a low prostate cancer incidence to those with a high incidence, and the lack of international variation in the prevalence of microfocal or latent prostatic tumors, environmental factors have been implicated. Obesity, western- type diet, increased total energy and saturated animal fat intake have all been suspected as potential risks. In contrast, consumption of vegetables and soy products and intake of certain vitamins and micronutrients, such as vitamins E and D, lycopene and selenium, may exert a protective effect. The hypothesis that dietary changes might affect the development of prostate cancer is strengthened by the fact that of all mammals almost only humans and dogs (at a much lower rate) get prostate cancer. Both have dramatically altered their diets during the last 15,000 years of their evolution, while other primates and mammals in which the disease is absent, made no significant changes. Case-control and cohort studies have failed to find a consistent association between prostate cancer risk and body mass index, dietary fat, total energy intake or other life-style changes. The conflicting results of past and recent trials are perhaps due to methodological and statistical limitations, measurement errors, different questionnaires, heterogeneity of prostate cancer patients, unsuspected biases and the retrospective nature of these investigations. Nevertheless, pending more extensive, well-controlled prospective studies, dietary and life-style changes should be advised, based on reduced morbidity and mortality from cardiovascular disease, the number 1 cause of death in western countries, and the number 1 or 2 cause of death in patients diagnosed with prostate cancer.
Authors and Affiliations
D. MELEKOS, I. MITSOGIANNIS
Measurement of patient satisfaction: A method for improving hospital quality and effectiveness
OBJECTIVE Measurement of patient satisfaction with the healthcare services provided by six general public hospitals in Athens and estimation of the gap between the patients' expectations and the effectiveness of the hosp...
Hydrothorax and spontaneous bacterial empyema in cirrhotic patients
Cirrhotic hydrothorax is defined as a significant pleural effusion in patients with cirrhosis of the liver and no primary cardiopulmonary disease. Its prevalence in patients with decompensated cirrhosis is 4% to 10%. Cir...
Cardiac troponins: Do they always indicate myocardial necrosis?
Cardiac troponins are proteins of the thin actin filaments of the cardiac muscles. They constitute very sensitive and specific markers for the detection of myocardial damage. The ability to assay their serum levels accu...
Central blood pressure: Non-invasive methods and technology for its estimation
Hypertension is a major risk factor for most cardiovascular diseases. Typically, it is identified by measuring blood pressure (BP) at the brachial artery, usually by cuff-sphygmomanometry. Although such a measurement may...
Tissue microarrays in immunohistochemical expression and molecular detection of DNA MMR system instability in colorectal cancer
OBJECTIVE To evaluate immunohistochemical expression DNA MMR (mismatch repair system) proteins (MLH1, MSH2 and MSH6-GTBP) in sporadic colon adenocarcinomas, correlating the results with chromosomal instability of chromos...